Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/adhm.201700294 | DOI Listing |
ASAIO J
October 2024
From the Inspired Therapeutics Limited Liability Company (LLC), Cocoa, Florida.
Importance: Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity. Aspirin as an antiplatelet agent is mandated along with vitamin K antagonists (VKAs) with continuous-flow LVADs without conclusive evidence of efficacy and safety.
View Article and Find Full Text PDFASAIO J
October 2023
From the Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Refurbishing single use extracorporeal membrane oxygenation (ECMO) oxygenators for in vitro research applications is common. However, the refurbishment protocols that are established in respective laboratories have never been evaluated. In the present study, we aim at proving the relevance of a well-designed refurbishing protocol by quantifying the burden of repeatedly reused oxygenators.
View Article and Find Full Text PDFJACC Heart Fail
December 2022
Center for Cardiovascular Analytics, Research, and Data Science, Providence Heart Institute, Providence St. Joseph Health, Portland, Oregon, USA. Electronic address:
J Thorac Cardiovasc Surg
February 2019
Division of Cardiothoracic Surgery, The Baylor College of Medicine/Michael E. Debakey VA Medical Center, Houston, Tex. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!